SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 4, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago
Insider cluster: 2 insiders, $68K total
Actionable Insight • Neutral

Insider sales are routine and immaterial. Focus on the earnings release showing revenue and profit declines, which overshadow this cluster.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$566.94
T+0 close · May 6, 2026 · via day close
Latest settled
−8.68%
T+60 · $517.71
Vs SPY
−10.80%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 7 $566.94entry
  2. T+1 · 6mo ago −0.44%α −1.27% · $564.44
  3. T+5 · 6mo ago +2.22%α +0.72% · $579.54
  4. T+20 · 6mo ago −3.08%α −6.22% · $549.47
  5. T+60 · 4mo ago −8.68%α −10.80% · $517.71

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO and CFO exercised stock options and sold a small number of shares (total ~$558K) coincident with Q1 2026 earnings release. Sales represent less than 0.01% of market cap, typical for tax-related transactions. No material insider selling signal.

Key Financial Metrics

Direction
selling
Total Value
$558.2K
Insiders
2

Key Facts

  • Total open-market sales by CEO and CFO: ~$558K
  • Sales represent 0.002% of $24.3B market cap
  • Both insiders exercised options concurrently with sales
  • Q1 2026 revenue declined 2% YoY, net income down 15%

Financial Impact

Trivial, $558K in insider sales, negligible relative to market cap

Risk Factors

  • Revenue decline and competitive pressure on Tyvaso franchise

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
77% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1778101531127

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026